A new once-a-day fentanyl citrate patch (Fentos® Tape) could be a new treatment option in patients with end-of-dose failure using a 72-h transdermal fentanyl matrix patch

Conclusions A once-a-day fentanyl citrate patch provided stable pain control. Its use may be considered as the dominant strategy for patients receiving a 72-h transdermal fentanyl not lasting 72 h.

http://link.springer.com/10.1007/s00520-015-2880-9

Source: Supportive Care in Cancer - January 28, 2016 Category: Cancer & Oncology Source Type: research